<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>3807</number>
    <updateDate>2023-01-12T17:52:24Z</updateDate>
    <updateDateIncludingText>2023-01-12T17:52:24Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2006-08-03</introducedDate>
    <congress>109</congress>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Hearings by</name>
            <date>2006-11-16T21:31:59Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2006-08-03T22:08:02Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2006-11-16</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 109-850.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2006-08-03</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2006-08-03</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S8818-8819)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-08-03</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-02-01</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S1531)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>E000285</bioguideId>
        <fullName>Sen. Enzi, Michael B. [R-WY]</fullName>
        <firstName>MICHAEL</firstName>
        <lastName>ENZI</lastName>
        <party>R</party>
        <state>WY</state>
        <middleName>B.</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>K000105</bioguideId>
        <fullName>Sen. Kennedy, Edward M. [D-MA]</fullName>
        <firstName>EDWARD</firstName>
        <lastName>KENNEDY</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>MOORE</middleName>
        <sponsorshipDate>2006-08-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000294</bioguideId>
        <fullName>Sen. DeWine, Mike [R-OH]</fullName>
        <firstName>MICHAEL</firstName>
        <lastName>DEWINE</lastName>
        <party>R</party>
        <state>OH</state>
        <sponsorshipDate>2006-09-05</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000596</bioguideId>
        <fullName>Sen. Dayton, Mark [D-MN]</fullName>
        <firstName>MARK</firstName>
        <lastName>DAYTON</lastName>
        <party>D</party>
        <state>MN</state>
        <sponsorshipDate>2006-09-08</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Biomedical engineering</name>
        </item>
        <item>
          <name>Clinical trials</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Conflict of interests</name>
        </item>
        <item>
          <name>Data banks</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drug interactions</name>
        </item>
        <item>
          <name>Drug utilization</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>Executive reorganization</name>
        </item>
        <item>
          <name>Federal advisory bodies</name>
        </item>
        <item>
          <name>Financial disclosure</name>
        </item>
        <item>
          <name>Food and Drug Administration (FDA)</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government paperwork</name>
        </item>
        <item>
          <name>Labeling</name>
        </item>
        <item>
          <name>Medical supplies</name>
        </item>
        <item>
          <name>Medical technology</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Product development</name>
        </item>
        <item>
          <name>Product safety</name>
        </item>
        <item>
          <name>Research centers</name>
        </item>
        <item>
          <name>Risk</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Technological innovations</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2006-08-03</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2006-09-25T19:32:22Z</updateDate>
        <text><![CDATA[ <p>Enhancing Drug Safety and Innovation Act of 2006 - Amends the Federal Food, Drug, and Cosmetic Act to require an application for approval for a new drug or biological product to include a proposed risk evaluation and mitigation strategy, which must include: (1) labeling for the drug for use by health care providers; (2) submission of reports for the drug; and (3) a statement as to whether the analysis and surveillance are sufficient to assess the serious risks of the drug.</p> <p> Establishes within the Food and Drug Administration (FDA) the Reagan-Udall Institute for Applied Biomedical Research to advance the Critical Path Initiative to modernize medical product development, accelerate innovation, and enhance product safety. Requires the Institute to have a Board of Directors. Allows the Board to establish one or more Critical Path Institutes to conduct research, education, and outreach and to modernize the sciences of developing, manufacturing, and evaluating the safety and effectiveness of diagnostics, devices, biologics, and drugs.</p> <p>Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and administer a clinical trial registry database and a clinical trial results database. Requires a responsible part for a clinical trial to submit clinical trial information to the Director for inclusion in the databases.</p> <p>Requires a member of a panel advising or recommending to the Secretary regarding FDA activities to disclose any financial involvements that the member may have. Directs the Secretary to recuse members with a high magnitude of financial involvement.</p>]]></text>
      </summary>
    </summaries>
    <title>Enhancing Drug Safety and Innovation Act of 2006</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Enhancing Drug Safety and Innovation Act of 2006</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Enhancing Drug Safety and Innovation Act of 2006</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2006-08-03T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-109s3807is/xml/BILLS-109s3807is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2006-11-16</actionDate>
      <text>Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 109-850.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
